Latest Regulatory News

New World Resources has upgraded its Antler Copper Deposit resource to 14.2 million tonnes at 3.8% copper equivalent, secured key permitting milestones, and recommended shareholders accept a $0.067 per share takeover offer from Kinterra Capital.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

EMVision Medical Devices has secured ethics approvals for two pivotal clinical studies and received a $400,000 milestone payment, marking significant progress toward commercialising its portable First Responder brain scanner.

Wildcat Resources has completed a positive Preliminary Feasibility Study for its Tabba Tabba lithium project in Western Australia, confirming a long-life mine with strong financial metrics and a clear path to development.

Viva Energy has reported a stronger-than-expected first half EBITDA, buoyed by operational efficiencies and refinery margins, even as convenience sales face headwinds from tobacco regulation.

Turners Automotive Group has issued over 324,000 new shares under its Dividend Reinvestment Plan for the FY25 final dividend, slightly increasing its capital base.

Domain Holdings Australia has received a draft class ruling from the ATO that aligns with its previously disclosed tax positions for the upcoming CoStar acquisition scheme. The final ruling, expected post-implementation, will provide definitive tax clarity for shareholders.

Capricorn Metals has received regulatory approval to expand its Karlawinda operations, enabling a 25% increase in gold production to 150,000 ounces annually. Construction is set to accelerate with key contracts extended and infrastructure upgrades underway.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Emyria has inked a pivotal agreement with Avive Health to launch its first Empax clinic in Queensland, expanding its innovative mental health treatment network. This move builds on its recent Medibank partnership, advancing accessible, reimbursed care for treatment-resistant conditions.

Buxton Resources reports significant progress across its exploration portfolio, including earthworks at Centurion, heritage survey completion at Madman, and a major graphite testwork success, while regaining full control of Fraser Range after IGO's exit.

Constellation Resources reports promising natural hydrogen exploration results across a massive 87,602 km² in Western Australia, alongside advancing copper-gold targets at Ularring and raising $1.1 million in a recent entitlement offer.